Clarinex
Product Images NDC 21695-815

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clarinex (NDC 21695-815). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (B7b0b1a0 2ab3 4697 Bee4 0cd7fd5088b9 01)

Chemical structure diagram of the active ingredient in Clarinex, showing a complex molecular configuration including a chlorinated aromatic ring, a piperazine ring, and a fused bicyclic system with a nitrogen heterocycle.*

FDA Label Image

Shering Logo (B7b0b1a0 2ab3 4697 Bee4 0cd7fd5088b9 02)

FDA Label Image

Clarinex 5mg (B7b0b1a0 2ab3 4697 Bee4 0cd7fd5088b9 03)

Label for Clarinex 5 mg tablets, bottle of 10, with Desloratadine as the active ingredient. The label shows the product NDC 21695-815-10 and includes batch and expiration date placeholders, along with details about packaging by Physician Partner and manufacturing by Cima Labs Inc. It features instructions for storage at controlled room temperature and a caution to keep medication out of children's reach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.